Member Info for PI_Winner

Agree Burgeseb.....data is king in this world....Yougov is significantly undervalued. Fully expect a rerate in the coming period and excellent results/update at the end of Jan.

P.S share price manipulation going on at the moment......Blackrock reduced by 0.04% yesterday. GLA.

Blackrock reduced their short yesterday by 0.02%....judging by the low volumes and then a small spike in volume yesterday...that will explain the sudden SP movement. GLA.

Dartron.....you cannot have voting rights without the equivalent shareholding.....it is company law basics. FACT - The rise on Monday was aligned to Ameriprise acquiring their stake. GLA.

And of course explains the rise to 508p earlier in the week when Ameriprise were acquiring their stake.

To be clear this stake relates to a holding of shares. If it was related to a financial instrument under number 7 of the RNS the stake would be in the second box....financial instrument! Great signal.......Ameriprise know their $hit. GLA.

Predictions in the short term is that the SP should be 600p+ . Yougov customer retention is excellent, their business model is first class, they have just completed 2 material acquisitions and when the operating model is integrated it will transform the business. Data is king these days and Yougov are in the right market at the right time. Dividend also coming at the end of the month.

The only time I am concerned about shorts is when there is 5 or 6 institutions shorting with 8%+ of the shares. Blackrock have less than 1% and it is guaranteed that they will have a material long position in addition....hedge funds...hedge. GLA.

Also 9p dividend end of Nov for shareholders. GLA.

Exactly Truthhurts3 the previous RNS was unaudited, the accounts are now verified. In the short term there is definitely 30%-40% upside from here. GLA.

Good find Smokinjoe03.

Valueplays short plays will be up in smoke pretty soon. :)

Plenty of Upside on Ocado at these prices......no brainer to invest from my point of view. GLA.

GLA....took my profits and out....I will review sentiment post budget.

Per Widerström, CEO of evoke, commented:

"I have now been in position for a year, and I am pleased that the turnaround of the business is working, with the first quarter of revenue growth since Q1 2022 and positive underlying trends. We are achieving our plans to improve trading in the short-term, while simultaneously radically transforming the Group's capabilities for the long-term.

Our online business is a clear growth engine for the Group and we saw a return to double-digit online revenue growth in our core markets in Q3 2024 underpinned by our focused market strategy and supported by important product investments and the results of our clearer customer value proposition and segmentation.

I am pleased to report a strong quarter of progress as we continue to implement our strategy for success and deliver our value creation plan. We are moving decisively and at pace to position evoke for long-term growth, and I look forward to providing further updates about our progress in the coming months."

Ha....I need to scan the RNS tomorrow morning.....but if the RNS aligns to the RNS update from a couple of months ago....you would think the executive will be competent enough to do that! Then 65p-70p tomorrow fingers crossed, but a mere guess.

The other benchmark to use is the obvious competitors i.e Entain etc albeit slightly different op models and propositions etc but same industry so relevant benchmark. GLA.

Acquired £300kish this morning....fancy a flutter based on the RNS in August. GLA.

Current trading and outlook:

· Q3 revenue growth for the period up to 10 August is consistent with the 5-9% target range given for H2

· No change to recently issued guidance with H2 2024 Adjusted EBITDA margin expected to improve to approximately 21%

· Clear drivers of improvement in revenue in H2 2024, with ongoing successful product launches, better player segmentation driving more effective bonus ratio, and new commercial leadership team producing compelling promotions, aligned with group CVP

· Significant improvement in profitability expected in H2 2024 as compared to H1 2024. This will be driven by the full period benefit of the £30 million cost saving programme, more effective marketing that is focused on our core customers and enhanced product. The benefits of increased focus and capabilities means that the online marketing ratio is expected to be ~18-19% in H2 compared to 25% in H1. Profitability will also benefit from reduced US B2C losses as part of the market exit, and the ongoing benefits of the new One Company operating model, with a reduction in layers in the business and increased usage of lower cost locations

· No change to existing FY25 expectations, including Adjusted EBITDA margin of at least 20%, with unchanged medium-term targets of 5-9% revenue growth per year, c.100bps of Adjusted EBITDA Margin expansion per year from 2025 onwards, and leverage of below 3.5x by the end of 2026

Exactly Carrington.....classic scenario of DYOR and do not follow the herd :)

North America Business

Q3 Performance

· Organic Revenue growth was 1.4% (1.3% year to date). Both Pest Control and Pest Control Services for residential, termite and commercial customers were up 1.4%.

· North America customer retention slightly increased in the period to 79.9%. Our pricing activities continued to be successful in passing cost inflation to our customers.

· After disappointing inbound digital lead flow in July and August, lead volume markedly improved in the second half of September. This was offset throughout Q3 by a slightly lower sales close rate and average dollar value for these leads.

· North America colleague retention increased further to 78.5% (30 June 2024: 77.8%), with improvement in both sales roles (up 0.4ppts to 70.6%) and service roles (up 1ppt to 75.3%).

· The North American leadership team has been strengthened, with a new Chief Marketing Officer and Chief Operating Officer appointed. The North America Chief Financial Officer left the business and the role is being covered on an interim basis by a senior finance colleague from within the Group, pending the appointment of a full time successor.

Group Revenue growth of 3.6% with Organic Revenue growth of 2.6%, including continued strength in Europe, UK and Asia

· North America Organic Revenue growth of 1.4% and North America Pest Control Organic Revenue growth of 1.4%

· Action plans to increase North America organic growth and rebalance the cost base have been strengthened since the September Trading Update

· The Terminix integration continues to go well. After a busy period in Q4 when we will be piloting new pay plans and new satellite branches, there will be a review early in the New Year to assess elements of the programme, delaying the timing of synergy delivery by about 2 to 3 months while the review is completed

· FY 24 revenue and margin guidance unchanged

· BBB (stable) rating reaffirmed by Fitch Ratings. Year-end leverage expected to be unchanged at 2.8x

The last couple of weeks is a classic case of herd mentality pre results. For me the bad news has already been circulated re drop in profits. Fully expect an update on a robust turnaround strategy tomorrow. For me there is huge upside and very little downside at these levels short and medium term. GLA.

The SP would only open at 145pish if the offer was accepted.

The offer of 145p has been on the table since the 23rd September and it has still not been rejected. There are loads of case studies to look at....the most recent one Rightmove and Rupert Murdochs offers to acquire. Each bid was rejected in short order as they should be.

The fact that the 145p bid has not been rejected after over 2 weeks displays to the market the executive have little confidence in the strategic direction of the company.......and the upside in the SP over the coming years....$hit executive team. The market are reacting to lack of commitment on the bid either way from the executive. GLA.

Now the bad news is out of the way, expect a positive update on the 17th October regarding turnaround strategy. Always happy to see activist investors materially involved to help shake things up. GLA.